References
Bach BA, Greene MI, Benacerraf B, Nisonoff A (1979) Mechanisms of regulation of cell-mediated immunity. IV. Azobenzenearsonate-specific suppressor factor(s) bear cross-reactive idiotypic determinants the expression of which is linked to the heavy-chain allotype linkage group of genes. J Exp Med 149: 1084
Benacerraf B, Germain R (1978) The immune response genes of the major histocompatibility complex. Immunol Rev 38: 70
Blomberg G, Geckeler WR, Weigert M (1972) Genetics of the antibody response to dextran in mice. Science 177: 178
Burnet FM (1948) The basis of allergic disease. Med J Aust 1: 29
Coovadia HM, Mackay IR, d'Apice AJF (to be published) Suppressor cells assayed by three different methods in patients with chronic active hepatitis and systemic lupus erythematosus. Clin Immunol Immunopath
De Groote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, Scheuer PJ, Schmid M, Thaler H, Uchlinger E, Wepler W (1968) A classification of chronic hepatitis. Lancet 2: 626
Eddleston ALWF, Williams R (1978) HLA and liver disease. Br Med Bull 34: 295
Farid NR, Newton RM, Elke PN, Marshall WH (1977) Gm phenotypes in autoimmune disease. J Immunogenet 4: 429
Freudenberg J, Baumann H, Arnold W, Berger J, Meyer zum Büschenfelde K-H (1977) HLA in different forms of chronic active hepatitis. A comparison between adult patients and children. Digestion 15: 260
Galbraith RM, Smith M, Mackenzie RM, Tee DE, Doniach D, Williams R (1974) High prevalence of sero-immunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirhosis. N Engl J Med 220: 63
Geall MG, Schoenfield LJ, Summerskill WHJ (1968) Classification and treatment of chronic active liver disease. Gastroenterology 55: 724
Hill RN, Clemens TL, Liu D-K, Vesell ES, Johnson DN (1975) Genetic control of chloroform toxicity in mice. Science 190: 159
Histocompatibility Testing 1977 (1978) Bodmer WF, Batchelor JR, Bodmer JG, Festenstein H, Morris PJ (eds) Munksgaard, Copenhagen
Hodgson HJF, Wands JR, Isselbacher KJ (1978) Alteration in suppressor cell activity in chronic active hepatitis. Proc Natl Acad Sci USA 75: 1549
Hooper B, Whittingham S, Mathews JD, Mackay IR, Curnow DH (1972) Autoimmunity in a rural community. Clin Exp Immunol 12: 79
International Group (1977) Acute and chronic hepatitis revisited. Lancet 2: 914
Leevy CM, Popper H, Sherlock S (1976) Diseases of the liver and biliary tract. Standardization of nomenclature, diagnostic criteria and diagnostic methodology. Fogarty International Center Proceedings No. 22, DHEW Publication No. (NIH) 76-725. U.S. Government Printing Office, Washington DC
Mackay IR (1968) Lupoid hepatitis and primary biliary cirrhosis: autoimmune diseases of the liver? Bull Rheum Dis 18: 487
Mackay IR (1975) Chronic active hepatitides. Front Gastrointest Res 1: 142
Mackay IR (1977) HLA and liver disease. In: Dausset J, Svejgaard A (eds) HLA and disease. Munksgaard, Copenhagen, p 186
Mackay IR, Morris PJ (1972) Association of autoimmune active chronic hepatitis with HL-A1,8. Lancet 2: 793
Mackay IR, Taft LI, Cowling DC (1956) Lupoid hepatitis. Lancet 2: 1323
Mackay IR, Tait BD (1980) HLA associations with autoimmune-type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies. Gastroenterology 79: 95
Mackay IR, Whittingham S, Tait B (1977) Genetic control of immune responsiveness in man. Vox Sang 32: 10
Mazzilli MC, Trabace S, Di Raimondo F, Visco G, Gandini E (1977) HLA and chronic active hepatitis. Digestion 15: 278
McDevitt HO, Bodmer WF (1974) HLA, immune response genes, and disease. Lancet 1: 1269
McFarlane IG, Wojcicka BM, Williams R (1980) Antigens of the human liver. Clin Exp Immunol 40: 1
Meyer zum Büschenfelde K-H, Hütteroth TH (1979) Autoantibodies against liver membrane antigens in chronic active liver diseases. In Eddleston ALWF, Weber JCP, Williams R (eds) Immune reactions in liver disease. Pitman Medical, London, p 12
Meyer zum Büschenfelde K-H, Manns M, Hütteroth TH, HopfU, Arnold W (1979) LM-Ag and LSP — two different target antigens involved in the immunopathogenesis of chronic active hepatitis? Clin Exp Immunol 37: 205
Miller KB, Schwartz RS (1979) Familial abnormalities of suppressor-cell function in systemic lupus erythematosus. N Engl J Med 301: 803
Morris PJ (1974) Histocompatibility systems, immune response, and disease in man. Contemp Top Immunobiol 3: 141
Morris PJ, Vaughan H, Tait BD, Mackay IR (1977) Histocompatibility antigen (HLA): associations with immunopathic diseases and with response to microbial antigens. Aust N Z J Med 7: 616
Nakao Y, Matsumoto H, Miyazaki T, Nishitani H, Ota K, Fujita T, Tsuji K (1980) Gm allotypes in myasthenia gravis. Lancet 1: 677
Opelz G, Vogten AJM, Summerskill WHJ, Schalm SW, Terasaki PI (1977) HLA determinants in chronic active liver disease: possible relation of HLA-Dw3 to prognosis. Tissue Antigens 9: 36
Penner E, Grabner G, Dittrich H, Mayr WR (1977) HLA antigens in HBs antigen positive chronic active hepatitis. Tissue Antigens 10: 63
Rose NR, Bacon LD, Sundick RS (1976) Genetic determinants of thyroiditis in the OS chicken. Transplant Rev 31: 264
Ryder LP, Andersen E, Svejgaard A (1978) An HLA map of Europe. Hum Hered 28: 171
Salaspuro MP, Laitinen OI, Lehtola J, Makkonen H, Rasanen JA, Sipponen P (1976) Immunological parameters, viral antibodies, and biochemical and histological findings in relatives of patients with chronic active hepatitis and primary biliary cirrhosis. Scand J Gastroenterol 11: 313
Schreffler DC, Chella DS (1975) The H2 major histocompatibility complex and the I immune response region: genetic variation, function and organization. Adv Immunol 20: 125
Svejgaard A, Christy M, Nerup J, Platz P, Ryder LP, Thomsen M (1978) HLA and autoimmune disease with special reference to the genetics of insulin-dependent diabetes. In: Rose NR, Bigazzi PE, Warner NL (eds) Genetic control of autoimmune disease. Elsevier North Holland Inc, New York, p 101
Tait BD, Mackay IR, Kastelan A, Dausset J, Mayer S, Okochi K (to be published) Chronic liver disease including chronic active hepatitis. In: Terasaki PI (ed) Histocompatibility testing 1980.
Talal N, Roubinian JR (1978) Sex hormones and autoimmunity. In: Rose NR, Bigazzi PE, Warner NL (eds) Genetic control of autoimmune disease, Elsevier North Holland Inc, New York, p 163
Vogten AJM, Shorter RG, Opelz G (1979) HLA and cell mediated immunity in HBsAg negative chronic active hepatitis. Gut 20: 523
Whittingham S, Mathews JD, Schanfield MS, Matthews JV, Tait BD, Morris PJ, Mackay IR (1980) Interactive effect of Gm allotypes and HLA-B locus antigens on the human antibody response to a bacterial antigen. Clin Exp Immunol 40: 8
Whittingham S, Mathews JD, Schanfield MS, Tait BD, Mackay IR (to be published) Interaction of HLA and Gm in autoimmune chronic active hepatitis. Clin Exp Immunol
Williams RM, Martin S, Falchuk KR, Trey C, Dubey DP, Cannady WG, Fitzpatrick D, Noreen H, Dupont B, Yunis EJ (1978) Increased frequency of HLA-DRw4 in chronic active hepatitis. Vox Sang 35: 366
Author information
Authors and Affiliations
Additional information
Aided by grants from the National Health and Medical Research Council of Australia
Rights and permissions
About this article
Cite this article
Mackay, I.R., Whittingham, S., Mathews, J.D. et al. Genetic determinants of autoimmune chronic active hepatitis. Springer Semin Immunopathol 3, 285–296 (1980). https://doi.org/10.1007/BF02054105
Issue Date:
DOI: https://doi.org/10.1007/BF02054105